This discussion summarizes the significant factors affecting the operating
results, financial condition, liquidity and cash flows of the Company and its
subsidiaries for the fiscal years ended March 31, 2022, and 2021. The discussion
and analysis that follows should be read together with the section entitled
"Cautionary Note Concerning Forward-Looking Statements" and our consolidated
financial statements and the notes to the consolidated financial statements
included elsewhere in this annual report on Form 10-K.



Except for historical information, the matters discussed in this section are
forward looking statements that involve risks and uncertainties and are based
upon judgments concerning various factors that are beyond the Company's control.
Consequently, and because forward-looking statements are inherently subject to
risks and uncertainties, the actual results and outcomes may differ materially
from the results and outcomes discussed in the forward-looking statements. You
are urged to carefully review and consider the various disclosures made by

us in
this report.


Currency and exchange rate





Unless otherwise noted, all currency figures quoted as "U.S. dollars", "dollars"
or "US$" refer to the legal currency of the United States. References to "Hong
Kong Dollar" are to the Hong Kong Dollar, the legal currency of the Hong Kong
Special Administrative Region of the People's Republic of China. Throughout this
report, assets and liabilities of the Company's subsidiaries are translated into
U.S. dollars using the exchange rate on the balance sheet date. Revenue and
expenses are translated at average rates prevailing during the period. The gains
and losses resulting from translation of financial statements of foreign
subsidiaries are recorded as a separate component of accumulated other
comprehensive income within the statement of stockholders' equity.



We are not required to obtain permission from the Chinese authorities to operate or to issue securities to foreign investors.





We are at a development stage company and reported a net loss of $442,982 and a
net income of $8,700 for the years ended March 31, 2022 and 2021, respectively.
We had current assets of $121,433 and current liabilities of $479,067 as of
March 31, 2022. As of March 31, 2021, our current assets and current liabilities
were $74,360 and $65,670, respectively. Our financial statements for the years
ended March 31, 2022 and 2021 have been prepared assuming that we will continue
as a going concern. Our continuation as a going concern is dependent upon the
continuing financial support from our stockholders. Our sources of capital in
the past have included the sale of equity securities, which include common stock
sold in private transactions and public offerings, capital leases and short-term
and long-term debts.



Results of Operations.


Comparison of the fiscal years ended March 31, 2022 and March 31, 2021





The following table sets forth certain operational data for the years indicated:



                                        Fiscal Years Ended March 31,
                                           2022                2021
Revenues                              $       548,571       $   211,549
Cost of revenue                              (439,343 )        (165,956 )
Gross profit                                  109,228            45,593
Sales and marketing expenses                 (226,366 )               -
General and administrative expenses           (47,543 )         (36,829 )
Professional fee                             (269,457 )             (64 )
Loss from operation                          (434,138 )           8,700
Other expense, net                             (8,844 )               -
(Loss) income before income tax              (442,982 )           8,700
Income tax expense                                  -                 -
Net (loss) income                            (442,982 )           8,700






  31






Revenue. We generated revenues of $548,571 and $211,549 for the years ended
March 31, 2022 and 2021, respectively, with a growth of 159.3%, arising from the
increasing demand in rapid tester kits during the continued trend of pandemic
threat in 2022 and 2021.


During the years ended March 31, 2022 and 2021, the following customer accounted for 10% or more of our total net revenues:





Customer name               Year ended March 31, 2022           March 31, 2022
                                              Percentage        Trade accounts
                          Revenues            of revenues         receivable
Uni-Alliance Limited   $        97,515                 18%     $          5,618




Customer name               Year ended March 31, 2021            March 31, 2021
                                               Percentage        Trade accounts
                           Revenues            of revenues         receivable
Uni-Alliance Limited   $        172,879                 82%     $          1,592




Cost of Revenue. Cost of revenue for the years ended March 31, 2022 and 2021 was
$439,343 and $165,956, respectively. with a growth of 164.73%, arising from the
increasing demand in rapid tester kits during the continued trend of pandemic
threat in 2022 and 2021.


During the years ended March 31, 2022, and 2021, the following vendor accounted for 10% or more of our total net cost of revenue:





Vendor name                                          Year ended March 31, 2022                March 31, 2022
                                                                   

Percentage of cost Trade accounts


                                            Cost of Revenues            of revenues              payable
Phase Scientific International Limited      $         403,568              

        92%     $                -




Vendor name                                           Year ended March 31, 2021                 March 31, 2021
                                                                          Percentage            Trade accounts
                                             Cost of Revenues         of cost of revenues          payable

Phase Scientific International Limited      $          165,956             

          100%     $          1,397



Gross Profit. We achieved a gross profit of $109,228 and $45,593 for the years ended March 31, 2022 and 2021, respectively.





Sales and marketing expenses. We incurred sales and marketing expenses of
$226,366 and $0 for the years ended March 31, 2022 and 2021, respectively. We
engaged with two consultants for expanding sale channels and developing
marketing strategies, analyzing and evaluating consumer data services for a term
of six months, with a compensation of 19,684,019 shares to be issued upon the
completion of the service contracts. The fair value of these shares was
$452,732, based on the current market price at the effective date of the
agreement and is being amortized over the service period.



General and Administrative Expenses ("G&A"). We incurred G&A expenses of $47,543
and $36,829 for the years ended March 31, 2022 and 2021, respectively. An
increase in G&A is in line with the sale growth, and primarily attributable to
the other expenses, such as bank charge, maintenance and repairs expense and
computer and internet expense.



Professional fee. We incurred professional fee of $269,457 and $64 for the years
ended March 31, 2022 and 2021, respectively, which mainly related to US audit
fee, US legal fee and compliance fee in connection with Form 10 filing.



Income Tax Expense. Our income tax expenses for the years ended March 31, 2022 and 2021 were $0.





Net (loss) income. As a result of the above, we reported net loss of $442,982
for the year ended March 31, 2022, while we reported $8,700 for the year ended
March 31, 2021.





  32





Liquidity and Capital Resources

As of March 31, 2022 and March 31, 2021, we had cash and cash equivalents of $111,396 and $72,768.

We expect to incur significantly greater expenses in the near future as we develop our product offerings or enter into strategic partnerships. We also expect our general and administrative expenses to increase as we expand our finance and administrative staff, add infrastructure, and incur additional costs related to being reporting act company, including directors' and officers' insurance and increased professional fees. In the next twelve months, we anticipate that we will need approximately $1-2 million to implement our business and sales growth plan. Thereafter, we expect that we will need approximately $1-2 million to meet our long-term liquidity and capital needs.

We have never paid dividends on our Common Stock. Our present policy is to apply cash to investments in product development, acquisitions or expansion; consequently, we do not expect to pay dividends on Common Stock in the foreseeable future.





Going Concern Uncertainties



Our continuation as a going concern is dependent upon improving our
profitability and the continuing financial support from our stockholders. Our
sources of capital in the past have included the sale of equity securities,
which include common stock sold in private transactions and public offerings,
short-term and long-term debts. Given the additional political and public health
challenges, our ability to obtain external financing or financing from existing
shareholders to fund our working capital needs has been materially and adversely
impacted, and there can be no assurance that we will be able to raise such
additional capital resources on satisfactory terms. We believe that our current
cash and other sources of liquidity discussed below are adequate to support
general operations for at least the next 12 months.



We require additional funding to meet its ongoing obligations and to fund
anticipated operating losses. Our auditor has expressed substantial doubt about
our ability to continue as a going concern. Our ability to continue as a going
concern is dependent on raising capital to fund its initial business plan and
ultimately to attain profitable operations. These consolidated financial
statements do not include any adjustments to reflect the possible future effects
on the recoverability and classification of assets and liabilities that may
result in the Company not being able to continue as a going concern.



We expect to incur marketing and professional and administrative expenses as
well expenses associated with maintaining our filings with the Commission. We
will require additional funds during this time and will seek to raise the
necessary additional capital. If we are unable to obtain additional financing,
we may be required to reduce the scope of our business development activities,
which could harm our business plans, financial condition and operating results.
Additional funding may not be available on favorable terms, if at all. We intend
to continue to fund its business by way of equity or debt financing and advances
from related parties. Any inability to raise capital as needed would have a
material adverse effect on our business, financial condition and results of
operations.



We also expect to continue to rely on cash generated through financing from our
existing shareholders and private placements of our securities to finance our
operations and future acquisitions in the next twelve months.



If we cannot raise additional funds, we will have to cease business operations. As a result, our common stock investors might lose all of their investment.





Cash Flows



The following summarizes our cash flows for the years ended March 31, 2022 and
2021:



                                                           Fiscal Years Ended March 31
                                                            2022                  2021

Net cash (used in) provided by operating activities $ (172,065 )

  $        8,891
Net cash provided by investing activities                            -                    -
Net cash provided by financing activities              $       211,087
 $       63,887






  33





Net Cash (Used In)/Provided By Operating Activities.





For the year ended March 31, 2022, net cash used in operating activities was
$172,065 which consisted primarily of a net loss of $442,982, an increase in
prepayment and other receivables of $4,419 and an increase in accounts
receivables of $4,026, offset by an increase in other payable and accruals

of
$279,362.



For the year ended March 31, 2021, net cash provided by operating activities was
$8,891, which consisted primarily of a net income of $8,700 and an increase in
accrued liabilities and other payables of $1,783, offset by an increase in
prepayment and other receivables of $1,592.



Net Cash Provided By Investing Activities.

For the year ended March 31, 2022, there was no net cash provided by investing activities.

For the year ended March 31, 2021, there was no net cash provided by investing activities.

Net Cash Provided By Financing Activities.





For the year ended March 31, 2022, net cash provided by financing activities was
$211,087 consisting of advance from a director of $478, proceed from issuance of
promissory notes of $77,052 from related parties, and note payable from the
Company's shareholder of $133,557.



For the year ended March 31, 2021, net cash provided by financing activities was $63,887 consisting primarily of advances from a director of $63,887.

Material Cash Requirements





We only have minimal income in the fiscal year 2021, and we expect to continue
to incur net losses for the foreseeable future. We expect net cash expended in
2023 fiscal year to be significantly higher than 2022 fiscal year. As of March
31, 2022, we had an accumulated deficit of $1,271,932. Our material cash
requirements are highly dependent upon the additional financial support from our
major shareholders in the next 12 - 18 months.



Off-Balance Sheet Arrangements

We have no outstanding off-balance sheet guarantees, interest rate swap transactions or foreign currency contracts. We do not engage in trading activities involving non-exchange traded contracts.

Contractual Obligations and Commercial Commitments

We have no contractual obligations and commercial commitments as of March 31, 2022.

Critical Accounting Policies and Estimates.





The preparation of financial statements in conformity with accounting principles
generally accepted in the United States requires our management to make
assumptions, estimates and judgments that affect the amounts reported, including
the notes thereto, and related disclosures of commitments and contingencies, if
any. We have identified certain accounting policies that are significant to the
preparation of our financial statements. These accounting policies are important
for an understanding of our financial condition and results of operations.
Critical accounting policies are those that are most important to the
presentation of our financial condition and results of operations and require
management's subjective or complex judgment, often as a result of the need to
make estimates about the effect of matters that are inherently uncertain and may
change in subsequent periods. Certain accounting estimates are particularly
sensitive because of their significance to financial statements and because of
the possibility that future events affecting the estimate may differ
significantly from management's current judgments. We believe the following
accounting policies are critical in the preparation of our financial statements.



  34






  · Use of estimates and assumptions




In preparing these consolidated financial statements, management makes estimates
and assumptions that affect the reported amounts of assets and liabilities in
the balance sheet and revenues and expenses during the years reported. Actual
results may differ from these estimates.



  · Basis of consolidation



The consolidated financial statements include the accounts of ENMI and its subsidiaries. All significant inter-company balances and transactions within the Company have been eliminated upon consolidation.





  · Cash and cash equivalents




Cash and cash equivalents are carried at cost and represent cash on hand, demand
deposits placed with banks or other financial institutions and all highly liquid
investments with an original maturity of three months or less as of the purchase
date of such investments.



  · Impairment of long-lived assets




In accordance with the provisions of ASC Topic 360, "Impairment or Disposal of
Long-Lived Assets", all long-lived assets such as plant and equipment and
intangible assets held and used by the Company are reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. Recoverability of assets to be held and used is
evaluated by a comparison of the carrying amount of an asset to its estimated
future undiscounted cash flows expected to be generated by the asset. If such
assets are considered to be impaired, the impairment to be recognized is
measured by the amount by which the carrying amounts of the assets exceed the
fair value of the assets.



  · Revenue recognition



ASC 606, Revenue from Contracts with Customers("ASC 606"), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity's contracts to provide goods or services to customers.

The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:





· identify the contract with a customer;
· identify the performance obligations in the contract;
· determine the transaction price;
· allocate the transaction price to performance obligations in the contract; and
· recognize revenue as the performance obligation is satisfied.




The Company derives its revenue from the sale of the rapid tester kits. The
Company sells its products directly to healthcare providers, retailers and
individual consumers through its retail channels. The Company considers customer
order confirmations to be a contract with the customer. Customer confirmations
are executed at the time an order is placed. Revenue is recognized when control
of the product is transferred to the customer (i.e., when the Company's
performance obligation is satisfied), which typically occurs at shipment date.
As a result, the Company has a present and unconditional right to payment and
record the amount due from the customer in accounts receivable.



For each contract, the Company considers the promise to transfer products to be
the only identified performance obligation. In determining the transaction
price, the Company evaluates whether the price is subject to refund or
adjustment to determine the net consideration to which the Company expects to be
entitled. The Company's revenues for the years ended March 31, 2022 and 2021 are
recognized at a point in time.





  35






  · Income taxes




The Company adopted the ASC 740 "Income tax" provisions of paragraph
740-10-25-13, which addresses the determination of whether tax benefits claimed
or expected to be claimed on a tax return should be recorded in the consolidated
financial statements. Under paragraph 740-10-25-13, the Company may recognize
the tax benefit from an uncertain tax position only if it is more likely than
not that the tax position will be sustained on examination by the taxing
authorities, based on the technical merits of the position. The tax benefits
recognized in the consolidated financial statements from such a position should
be measured based on the largest benefit that has a greater than fifty percent
(50%) likelihood of being realized upon ultimate settlement. Paragraph
740-10-25-13 also provides guidance on de-recognition, classification, interest
and penalties on income taxes, accounting in interim periods and requires
increased disclosures. The Company had no material adjustments to its
liabilities for unrecognized income tax benefits according to the provisions of
paragraph 740-10-25-13.



The estimated future tax effects of temporary differences between the tax basis
of assets and liabilities are reported in the accompanying balance sheets, as
well as tax credit carry-backs and carry-forwards. The Company periodically
reviews the recoverability of deferred tax assets recorded on its balance sheets
and provides valuation allowances as management deems necessary.



  · Foreign currencies translation




Transactions denominated in currencies other than the functional currency are
translated into the functional currency at the exchange rates prevailing at the
dates of the transaction. Monetary assets and liabilities denominated in
currencies other than the functional currency are translated into the functional
currency using the applicable exchange rates at the balance sheet dates. The
resulting exchange differences are recorded in the consolidated statement of
operations.



The reporting currency of the Company is United States Dollar ("US$") and the
accompanying consolidated financial statements have been expressed in US$. In
addition, the Company is operating in Hong Kong and maintains its books and
record in its local currency, Hong Kong Dollars ("HKD"), which is a functional
currency as being the primary currency of the economic environment in which the
operations are conducted. In general, for consolidation purposes, assets and
liabilities of its subsidiary whose functional currency is not US$ are
translated into US$, in accordance with ASC Topic 830-30, "Translation of
Financial Statement", using the exchange rate on the balance sheet date.
Revenues and expenses are translated at average rates prevailing during the
period. The gains and losses resulting from translation of financial statements
of foreign subsidiary are recorded as a separate component of accumulated other
comprehensive income within the statements of changes in stockholder's equity.



  · Comprehensive income




ASC Topic 220, "Comprehensive Income", establishes standards for reporting and
display of comprehensive income, its components and accumulated balances.
Comprehensive income as defined includes all changes in equity during a period
from non-owner sources. Accumulated other comprehensive income, as presented in
the accompanying consolidated statements of changes in stockholders' equity,
consists of changes in unrealized gains and losses on foreign currency
translation. This comprehensive income is not included in the computation of
income tax expense or benefit.



  · Net loss per share




The Company calculates net loss per share in accordance with ASC 260, Earnings
per Share. Basic income per share is computed by dividing the net income by the
weighted-average number of common shares outstanding during the period. Diluted
income per share is computed similar to basic income per share except that the
denominator is increased to include the number of additional common shares that
would have been outstanding if the potential common stock equivalents had been
issued and if the additional common shares were dilutive.









  36






  · Stock based compensation




Pursuant to ASU 2018-07, the Company follows ASC 718, Compensation-Stock
Compensation ("ASC 718"), which requires the measurement and recognition of
compensation expense for all share-based payment awards (employee or
non-employee), are measured at grant-date fair value of the equity instruments
that an entity is obligated to issue. Restricted stock units are valued using
the market price of the Company's common shares on the date of grant. The
Company uses a Black-Scholes option model to estimate the fair value of employee
stock options at the date of grant. As of March 31, 2022, those shares issued
and stock options granted for service compensations were immediately vested, and
therefore these amounts are thus recognized as expense in the operation.



  · Segment reporting




ASC Topic 280, "Segment Reporting" establishes standards for reporting
information about operating segments on a basis consistent with the Company's
internal organization structure as well as information about geographical areas,
business segments and major customers in the consolidated financial statements.



  · Retirement plan costs




Contributions to retirement plans (which are defined contribution plans) are
charged to general and administrative expenses in the accompanying statements of
operation as the related employee service are provided.



  · Related parties



The Company follows the ASC 850-10, "Related Party Disclosures" for the identification of related parties and disclosure of related party transactions.


Pursuant to section 850-10-20 the related parties include a) affiliates of the
Company; b) entities for which investments in their equity securities would be
required, absent the election of the fair value option under the Fair Value
Option Subsection of section 825-10-15, to be accounted for by the equity method
by the investing entity; c) trusts for the benefit of employees, such as pension
and Income-sharing trusts that are managed by or under the trusteeship of
management; d) principal owners of the Company; e) management of the Company; f)
other parties with which the Company may deal if one party controls or can
significantly influence the management or operating policies of the other to an
extent that one of the transacting parties might be prevented from fully
pursuing its own separate interests; and g) other parties that can significantly
influence the management or operating policies of the transacting parties or
that have an ownership interest in one of the transacting parties and can
significantly influence the other to an extent that one or more of the
transacting parties might be prevented from fully pursuing its own separate
interests.



The consolidated financial statements shall include disclosures of material
related party transactions, other than compensation arrangements, expense
allowances, and other similar items in the ordinary course of business. However,
disclosure of transactions that are eliminated in the preparation of
consolidated or combined financial statements is not required in those
statements. The disclosures shall include: a) the nature of the relationship(s)
involved; b) a description of the transactions, including transactions to which
no amounts or nominal amounts were ascribed, for each of the periods for which
income statements are presented, and such other information deemed necessary to
an understanding of the effects of the transactions on the financial statements;
c) the dollar amounts of transactions for each of the periods for which income
statements are presented and the effects of any change in the method of
establishing the terms from that used in the preceding period; and d) amount due
from or to related parties as of the date of each balance sheet presented and,
if not otherwise apparent, the terms and manner of settlement.









  37






  · Commitments and contingencies




The Company follows the ASC 450-20, "Contingencies" to report accounting for
contingencies. Certain conditions may exist as of the date the financial
statements are issued, which may result in a loss to the Company but which will
only be resolved when one or more future events occur or fail to occur. The
Company assesses such contingent liabilities, and such assessment inherently
involves an exercise of judgment. In assessing loss contingencies related to
legal proceedings that are pending against the Company or un-asserted claims
that may result in such proceedings, the Company evaluates the perceived merits
of any legal proceedings or un-asserted claims as well as the perceived merits
of the amount of relief sought or expected to be sought therein.



If the assessment of a contingency indicates that it is probable that a material
loss has been incurred and the amount of the liability can be estimated, then
the estimated liability would be accrued in the Company's consolidated financial
statements. If the assessment indicates that a potentially material loss
contingency is not probable but is reasonably possible, or is probable but
cannot be estimated, then the nature of the contingent liability, and an
estimate of the range of possible losses, if determinable and material, would be
disclosed.



Loss contingencies considered remote are generally not disclosed unless they
involve guarantees, in which case the guarantees would be disclosed. Management
does not believe, based upon information available at this time that these
matters will have a material adverse effect on the Company's financial position,
results of operations or cash flows. However, there is no assurance that such
matters will not materially and adversely affect the Company's business,
financial position, and results of operations or cash flows.



  · Fair value of financial instruments




The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards
Codification for disclosures about fair value of its financial instruments and
has adopted paragraph 820-10-35-37 of the FASB Accounting Standards Codification
("Paragraph 820-10-35-37") to measure the fair value of its financial
instruments. Paragraph 820-10-35-37 of the FASB Accounting Standards
Codification establishes a framework for measuring fair value in generally
accepted accounting principles (GAAP), and expands disclosures about fair value
measurements. To increase consistency and comparability in fair value
measurements and related disclosures, paragraph 820-10-35-37 of the FASB
Accounting Standards Codification establishes a fair value hierarchy which
prioritizes the inputs to valuation techniques used to measure fair value into
three (3) broad levels. The fair value hierarchy gives the highest priority to
quoted prices (unadjusted) in active markets for identical assets or liabilities
and the lowest priority to unobservable inputs. The three (3) levels of fair
value hierarchy defined by paragraph 820-10-35-37 of the FASB Accounting
Standards Codification are described below:



Level 1 Quoted market prices available in active markets for identical assets or

liabilities as of the reporting date.

Level 2 Pricing inputs other than quoted prices in active markets included in

Level 1, which are either directly or indirectly observable as of the

reporting date.

Level 3 Pricing inputs that are generally observable inputs and not corroborated


          by market data.




Financial assets are considered Level 3 when their fair values are determined
using pricing models, discounted cash flow methodologies or similar techniques
and at least one significant model assumption or input is unobservable.



The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.











  38






The carrying amounts of the Company's financial assets and liabilities, such as
cash and cash equivalents, approximate their fair values because of the short
maturity of these instruments.



Recently Issued Accounting Pronouncements





In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting
Standards Update (ASU) 2016-13, Financial Instruments - Credit Losses
(Topic 326). The new standard amends guidance on reporting credit losses for
assets held at amortized cost basis and available-for-sale debt securities. In
February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses
(Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to
SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective
Date Related to Accounting Standards Update No. 2016-02, Leases
(Topic 842), which amends the effective date of the original pronouncement for
smaller reporting companies. ASU 2016-13 and its amendments will be effective
for the Company for interim and annual periods in fiscal years beginning after
December 15, 2022. The Company believes the adoption will modify the way the
Company analyzes financial instruments, but it does not anticipate a material
impact on results of operations. The Company is in the process of determining
the effects the adoption will have on its consolidated financial statements.



In October 2020, the FASB issued ASU 2020-08, Codification Improvements to
Subtopic 310-20, Receivables - Nonrefundable Fees and Other Costs, which
clarifies that, for each reporting period, an entity should reevaluate whether a
callable debt security is within the scope of ASC 310-20-35-33. For public
business entities, ASU 2020-08 is effective for fiscal years, and interim
periods within those fiscal years, beginning after December 15, 2020. Early
application is not permitted. For all other entities, ASU 2020-08 is effective
for fiscal years beginning after December 15, 2021, and interim periods within
fiscal years beginning after December 15, 2022. This Update is not expected to
have a significant impact on the Company's consolidated financial statements.



In October 2020, the FASB issued ASU 2020-10, Codification Improvements, which
makes minor technical corrections and clarifications to the ASC. The amendments
in Sections B and C of the ASU are effective for annual periods beginning after
December 15, 2020, for public business entities. For all other entities, the
amendments are effective for annual periods beginning after December 15, 2021,
and interim periods within annual periods beginning after December 15, 2022.
This Update is not expected to have a significant impact on the Company's
consolidated financial statements.



The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

© Edgar Online, source Glimpses